Results 11 to 20 of about 9,288,830 (350)

Metabolomic rewiring promotes endocrine therapy resistance in breast cancer [PDF]

open access: yesCancer Research, 2023
Approximately one-third of endocrine-treated women with estrogen receptor-alpha positive (ER+) breast cancers (BC) are at risk of recurrence due to intrinsic or acquired resistance.
Songyeon Ahn   +10 more
semanticscholar   +2 more sources

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review

open access: yesCancers, 2022
Simple Summary Many persons diagnosed with breast cancer are treated with endocrine therapy and will experience the side effects of endocrine therapy. Cognitive adverse effects of endocrine therapy are increasingly being recognised, and can significantly
L. Haggstrom   +5 more
semanticscholar   +2 more sources

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

open access: yesNature Communications, 2021
CDK4/6 inhibitors in combination with endocrine therapy has shown efficacy in ER + breast cancer patients but resistance can occur. Here, the authors demonstrate that co-targeting CDK4/6 and AKT with endocrine therapy prevents acquired resistance and ...
Carla L. Alves   +13 more
doaj   +2 more sources

Primary endocrine therapy of locally advanced breast cancer patients [PDF]

open access: yesArchive of Oncology, 2003
Primary endocrine therapy has been traditionally reserved for elderly and unfit locally advanced breast cancer patients (LABC patients). In this group, the primary endocrine therapy could not be adequately compared to primary chemotherapy.
Nešković-Konstantinović Zora B.
doaj   +2 more sources

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement

open access: yesPatient Preference and Adherence, 2018
Pin Gao,1 Lili You,2 Di Wu,1 Aiping Shi,1 Qing Miao,3 Ujala Rana,4 Dustin Paul Martin,3 Ye Du,1 Gang Zhao,1 Bing Han,1 Chao Zheng,5 Zhimin Fan1 1Department of Breast Surgery, First Hospital of Jilin University, Changchun, Jilin, China; 2Department of ...
Gao P   +11 more
doaj   +1 more source

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?

open access: yesPatient Preference and Adherence, 2018
Jessica Keim-Malpass,1 Aubrey Doede,1 Shayna L Showalter2 1Department of Acute and Specialty Care, University of Virginia School of Nursing, Charlottesville, VA 22908, USA; 2Department of Surgery, University of Virginia School of Medicine ...
Keim-Malpass J, Doede A, Showalter SL
doaj   +1 more source

Yoga: An endocrine therapy

open access: yesIndian Journal of Endocrinology and Metabolism, 2015
Prashant Kaduskar, K M Suryanarayana
doaj   +3 more sources

The potential of chimeric antigen receptor -T cell therapy for endocrine cancer

open access: yesWorld Journal of Surgical Oncology
Endocrine cancer, a relatively rare and heterogeneous tumor with diverse clinical features. The facile synthesis of hormones further complicates endocrine cancer treatment.
Ruonan Yu   +5 more
doaj   +2 more sources

Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours

open access: yesCommunications Biology
ER/PR+HER2- breast tumours are the most predominant subtype of breast cancer worldwide, including India. Unlike TNBCs, these tumours can be treated with anti-estrogens or aromatase inhibitors.
Arnab Ghosh   +8 more
doaj   +2 more sources

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy. [PDF]

open access: yes, 2022
Immunotherapy treatment with checkpoint inhibitors (CPI) (CTLA-4 and PD-1 inhibitors) significantly improves survival in a number of cancers. Treatment can be limited by immune-mediated adverse effects including endocrinopathies such as hypophysitis ...
Cooksley, T   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy